Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 306 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Merkel cell carcinoma of the eyelid management and prognosisHerbert, H.; Sun, M.; Selva, D.; Fernando, B.; Saleh, G.; Beaconsfield, M.; Collin, R.; Uddin, J.; Meligonis, G.; Leatherbarrow, B.; Ataullah, S.; Irion, L.; McLean, C.; Huilgol, S.; Davis, G.; Sullivan, T.
2014Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapyPuri, R.; Nissen, S.; Shao, M.; Uno, K.; Kataoka, Y.; Kapadia, S.; Tuzcu, E.; Nicholls, S.
2011Management of hot flashes in patients who have breast cancer with Venlafaxine and Clonidine: a randomized, double-blind, placebo-controlled trialBoekhout, A.; Vincent, A.; Dalesio, O.; van den Bosch, J.; Foekema-Tons, J.; Adriaansz, S.; Sprangers, S.; Nuijen, B.; Beijnen, J.; Schellens, J.
2014The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17Sommeijer, D.; Karapetis, C.; Zalcberg, J.; Tu, D.; Jonker, D.; Simes, J.; Tebbutt, N.; Yip, D.; Price, T.; O'Callaghan, C.
2013EditorialLisy, K.
2014Magnesium sulphate for preventing preterm birth in threatened preterm labourCrowther, C.; Brown, J.; McKinlay, C.; Middleton, P.
2014Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice dailyHughes, T.; Hochhaus, A.; Kantarjian, H.; Cervantes, F.; Guilhot, F.; Niederwieser, D.; Le Coutre, P.; Rosti, G.; Ossenkoppele, G.; Lobo, C.; Shibayama, H.; Fan, X.; Menssen, H.; Kemp, C.; Larson, R.; Saglio, G.
2011Maternal depression and child development after prenatal DHA supplementation: ReplyMakrides, M.; Yelland, L.; Gibson, R.
2013The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trialNahuis, M.; Weiss, N.; van der Veen, F.; Mol, B.; Hompes, P.; Oosterhuis, G.; Lambalk, C.; Smeenk, J.; Koks, C.; van Golde, R.; Laven, J.; Cohlen, B.; Fleischer, K.; Goverde, A.; Gerards, M.; Klijn, N.; Nekrui, L.; van Rooij, I.; Hoozemans, D.; van Wely, M.
2015Quantifying not only bone loss, but also soft tissue swelling, in a murine inflammatory arthritis model using micro-computed tomographyPerilli, E.; Cantley, M.; Marino, V.; Crotti, T.; Smith, M.; Haynes, D.; Dharmapatni, A.